Nauheim, Germany

Marcus Eber



Average Co-Inventor Count = 1.5

ph-index = 1


Location History:

  • Floersheim, DE (2016)
  • Nauheim, DE (2019)

Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Marcus Eber in Oligopeptides

Introduction

Marcus Eber, an innovative inventor based in Nauheim, Germany, has made significant contributions to the field of pharmaceutical compositions. With a total of two patents to his name, his work primarily revolves around the use of oligopeptides in treating disorders. Eber's expertise in this area showcases the potential of oligopeptides in modern medicine.

Latest Patents

Eber's most recent patents focus on the development of pharmaceutical compositions that utilize oligopeptides. The first patent, titled "Method of treating disorders using a pharmaceutical composition of oligopeptides," outlines a composition that includes cyclic oligopeptides along with lipophilic and/or amphiphilic compounds. This invention specifies the methods of creating these compositions, highlighting the innovative ways oligopeptides can be employed to address various medical issues.

The second patent, "Pharmaceutical composition comprising oligopeptides," also emphasizes the use of similar components, reinforcing Eber's commitment to advancing the therapeutic applications of oligopeptides through detailed exploration of their compositions and formulations.

Career Highlights

Marcus Eber is affiliated with Merck Patent GmbH, where he continues to work on groundbreaking inventions in pharmaceutical research. His role at the company allows him to collaborate closely with other professionals in the industry, which aids in the realization of his innovative ideas.

Collaborations

Eber has had the opportunity to work alongside talented colleagues such as Simon Lawrence Goodman and Christiane Amendt. These collaborations not only enhance the innovative process but also contribute to a productive environment where diverse ideas can flourish, leading to the development of novel pharmaceutical solutions.

Conclusion

In conclusion, Marcus Eber stands out as a key figure in the realm of pharmaceutical innovation, particularly through his work with oligopeptides. With his patents contributing to advancements in medical treatments, Eber's career at Merck Patent GmbH illustrates the impact inventors can have on the healthcare industry. His ongoing commitment to research and collaboration will undoubtedly lead to further breakthroughs in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…